Hovione has over 57 years of experience as a CDMO and is currently a fully integrated supplier offering from drug substance to drug product intermediate to drug product. With four FDA inspected sites in the U.S., China, Ireland, and Portugal, and development laboratories in Lisbon and New Jersey, the company provides branded pharmaceutical customers services for the development and compliant manufacture of innovative drugs, including support highly potent compounds. For generic pharmaceutical customers the company offers niche off-patent API products. In the inhalation area, Hovione is the only independent company offering services comprising drug substance, drug product intermediate, formulation and devices for dry powder inhalation. We remain fully committed to solving complex problems and delivering solutions that are highly valued by our customers. We are a company with a culture based on innovation, quality and delivery.